WallStreetZenWallStreetZen

NASDAQ: BIOR
Biora Therapeutics Inc Stock Ownership - Who owns Biora Therapeutics?

Insider buying vs selling

Have Biora Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Clarke NeumannSenior Vice President General Counsel and Secretary2023-08-1536,183$3.14
$113.61kSell
Aditya P. MohantyChief Executive Officer2023-08-15117,881$3.14
$370.15kSell
Eric DesparbesChief Financial Officer2023-08-1540,022$3.14
$125.67kSell
Aditya P. MohantyChief Executive Officer2023-05-1511,249$3.35
$37.68kSell
Eric DesparbesChief Financial Officer2023-05-152,807$3.35
$9.40kSell
Clarke NeumannSenior Vice President General Counsel and Secretary2023-05-152,368$3.35
$7.93kSell
Clarke NeumannSenior Vice President General Counsel and Secretary2023-03-1510,683$2.56
$27.35kSell
Aditya P. MohantyChief Executive Officer2023-03-1522,252$2.56
$56.97kSell
Eric DesparbesChief Financial Officer2023-03-1511,216$2.56
$28.71kSell

1 of 1

BIOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIOR insiders and whales buy or sell their stock.

BIOR Shareholders

What type of owners hold Biora Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Athyrium Capital Management LP153.55%36,396,907$30.57MInsider
Athyrium Opportunities Fund A LP153.55%36,396,907$30.57MInsider
Harry Stylli62.51%14,816,522$12.45MInsider
Athyrium Opportunities Iii Coinvest 1 LP46.11%10,929,763$9.18MInsider
Athyrium Capital Management LP46.11%10,929,762$9.18MInstitution
Aditya P. Mohanty6.49%1,539,492$1.29MInsider
Eric Desparbes2.55%603,662$507.08kInsider
Vanguard Group Inc2.14%507,935$426.67kInstitution
Clarke Neumann2.08%492,193$413.44kInsider
Damon Silvestry1.23%291,499$244.86kInsider

1 of 3

BIOR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIOR10.43%89.57%Net Selling
NTRB2.49%72.04%
AIM8.47%9.64%Net BuyingNet Buying
SNSE11.79%72.20%Net SellingNet Selling
OCEA13.38%75.49%

Biora Therapeutics Stock Ownership FAQ

Who owns Biora Therapeutics?

Biora Therapeutics (NASDAQ: BIOR) is owned by 50.13% institutional shareholders, 430.34% Biora Therapeutics insiders, and 0.00% retail investors. Athyrium Capital Management LP is the largest individual Biora Therapeutics shareholder, owning 36.40M shares representing 153.55% of the company. Athyrium Capital Management LP's Biora Therapeutics shares are currently valued at $29.81M.

If you're new to stock investing, here's how to buy Biora Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.